Skip to main content
Log in

Treatment considerations in children aged 0–5 years

  • Management Of Asthma: A Consensus Report Of Pediatricians
  • Published:
Lung Aims and scope Submit manuscript

Abstract

Children in the first year of life have a less satisfactory response to treatment, but it is still worthwhile using bronchodilators by oral or nebulized route. In more severe cases, cromolyn or nebulized steroids are needed. Over 1 year, response to therapy is better and metered-dose inhalers with spacers become an easier way to deliver medication, although in severe acute attacks the nebulized route remains the preferred one.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rutter N, Milner AD, Hiller EJ (1975) Effect of bronchodilators on respiratory resistance in infants and young children with bronchiolitis and wheezy bronchitis. Arch Dis Child 50:719–722

    Article  PubMed  CAS  Google Scholar 

  2. Soto ME, Sly PD, Uren E, Taussig LM, Landau LI (1985) Bronchodilator response during acute viral bronchiolitis in infancy. Pediatr Pulmonol 1:85–90

    Article  PubMed  CAS  Google Scholar 

  3. König P (1978) Treatment of severe attacks of asthma in children with nebulizedβ 2 adrenergic agents. Ann Allergy 40:185–188

    PubMed  Google Scholar 

  4. Lowell DI, Lister G, vonKoss H, McCarthy P (1987) Wheezing in infants: The response to epinephrine. Pediatrics 79:939–945

    PubMed  CAS  Google Scholar 

  5. Hodges IGC, Groggins RC, Milner AD, Stokes GM (1981) Bronchodilator effect of inhaled ipratropium bromide in wheezy toddlers. Arch Dis Child 56:729–732

    Article  PubMed  CAS  Google Scholar 

  6. Geller-Bernstein C, Levin S (1982) Nebulised sodium cromoglycate in the treatment of wheezy bronchitis in infants and young children. Respiration 43:294–298

    Article  PubMed  CAS  Google Scholar 

  7. Maayan C, Itzhaki T, Bar-Yishay E, Gross S, Tal A, Godfrey S (1986) The functional response of infants with persistent wheezing to nebulized beclomethasone dipropionate. Pediatr Pulmonol 2:9–14

    Article  PubMed  CAS  Google Scholar 

  8. Webb MSC, Milner AD, Hiller EJ, Henry RL (1986) Nebulised beclomethasone dipropionate suspension. Arch Dis Child 61:1108–1110

    Article  PubMed  CAS  Google Scholar 

  9. Newth CJL, Newth CV, Turner JAP (1982) Comparison of nebulized sodium cromoglycate and oral theophylline in controlling symptoms of chronic asthma in pre-school children: a double blind study. Aust NZ J Med 12:232–238

    CAS  Google Scholar 

  10. Storr J, Lenney CA, Lenney W (1986) Nebulised beclomethasone dipropionate in preschool asthma. Arch Child 61:270–273

    Article  CAS  Google Scholar 

  11. Godfrey S, Avital A, Rosler A, Mandelberg A, Uwyyed K (1987) Nebulised budesonide in severe infantile asthma. Lancet 2:851–852

    Article  PubMed  CAS  Google Scholar 

  12. König P, Gayer D, Kantak A, Kreutz C, Douglass B, Hordvik NL (1988) A trial of metaproterenol by metered-dose inhaler and two spacers in preschool asthmatics. Pediatr Pulmonol 5:247–251

    Article  PubMed  Google Scholar 

  13. Conner WT, Dolovich MB, Frame RA, Newhouse MT (1989) Reliable salbutamol administration in 6- to 36-month-old children by means of a metered dose inhaler and Aerochamber with mask. Pediatr Pulmonol 6:263–267

    Article  PubMed  CAS  Google Scholar 

  14. Warner JO, Götz M, Milner T, Landau LI, Levison H, Pedersen S, Silverman M (1989) Management of asthma; an international view. Arch Dis Child 64:1065–1079

    Article  PubMed  CAS  Google Scholar 

  15. Beasley R, Roche WR, Roberts JA, Holgate ST (1989) Cellular events in bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 139:806–817

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

König, P. Treatment considerations in children aged 0–5 years. Lung 168 (Suppl 1), 243–245 (1990). https://doi.org/10.1007/BF02718138

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02718138

Key words

Navigation